Free Trial

Cronos Group (TSE:CRON) Stock Price Up 4.6% - Should You Buy?

Cronos Group logo with Medical background

Cronos Group Inc. (TSE:CRON - Get Free Report) was up 4.6% on Wednesday . The stock traded as high as C$2.73 and last traded at C$2.73. Approximately 148,526 shares were traded during trading, a decline of 24% from the average daily volume of 195,231 shares. The stock had previously closed at C$2.61.

Cronos Group Stock Performance

The stock has a market cap of C$728.82 million, a P/E ratio of -15.36, a P/E/G ratio of 0.12 and a beta of 1.02. The company has a current ratio of 24.24, a quick ratio of 24.01 and a debt-to-equity ratio of 0.17. The company has a 50-day moving average price of C$2.70 and a two-hundred day moving average price of C$2.70.

About Cronos Group

(Get Free Report)

Cronos Group, headquartered in Toronto, Canada cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis to Poland and Germany. In addition, it has entered joint ventures in Israel, Colombia, and Australia to drive further international cultivation and distribution growth.

Further Reading

Should You Invest $1,000 in Cronos Group Right Now?

Before you consider Cronos Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cronos Group wasn't on the list.

While Cronos Group currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 “Boring” Mega Cap Stocks to Turn Into Pure Profit
Joby vs. Archer: The $10 Billion eVTOL Battle
3 Small-Cap Biotech Stocks With Catalysts Too Big to Ignore

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines